We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.


Aurora Diagnostics Acquires University Pathologists

Aurora Diagnostics Acquires University Pathologists content piece image
Listen with
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: Less than a minute

 Aurora Diagnostics has announced the acquisition of University Pathologists, including its affiliated technical lab, University Pathologists Diagnostics.

University Pathologists, based in Warwick, R.I., provides hospital-based professional anatomic pathology services to eight hospitals affiliated with several systems and – through its technical lab in Fall River, Mass. – to various physician practices in Connecticut, Massachusetts and Rhode Island.

“We welcome the highly regarded pathologists and lab professionals of University Pathologists to Aurora Diagnostics,” said Daniel D. Crowley, Chairman and Chief Executive Officer of Aurora. “University Pathologists and its lab are known for providing excellent pathology services, and we look forward to serving the region with them.”

“Aurora has a strong focus on quality, service and local community relationships – values that we share – making this an excellent strategic partner for our organization,” said Dr. Jila Khorsand, Managing Director of University Pathologists. “We are very pleased to be part of this growing company.”

Other Aurora Diagnostics locations in New England include DermDX in Boston, Hallmark Pathology in Medford, Mass., and Seacoast Pathology in Exeter, N.H.

This acquisition is Aurora’s tenth acquisition overall and eighth in the hospital laboratory sector since 2013. Serving more than 100 hospitals throughout the U.S., Aurora Diagnostics is a leader in providing hospital lab management services.

Additionally, its Aurora Research Institute subsidiary is a leader in helping hospitals and independent labs to ethically provide tissue and blood samples to researchers on the cutting edge of research for effective cancer treatments.

“We continue to expand our capabilities as we serve the needs of physicians and hospitals in the rapidly changing healthcare environment,” said Mr. Crowley. Terms of the transaction were not disclosed.